Previously, we demonstrated that the addition of CXCL4 to CXCL12 chemokine led to the inhibition of CXCL12-induced migration of triple-negative MDA-MB-231 breast cancer cells in a wound-healing assay16. Here, CXCL12 is linked to breast cancer.